# If you had invested $1,000 in Eli Lilly and Company (LLY)

Source: https://www.equity-rank.com/if-you-invested/LLY

10 years ago (Mon, Nov 7, 2016), $1,000 in LLY grew to **$21,431** by Fri, Nov 6, 2026 with dividends reinvested ($18,327 on price alone). The same $1,000 in SPY grew to $4,042. Along the way LLY fell as much as -34.5% from a high. Past results do not tell you what happens next.

| Invested | LLY, dividends reinvested | Per year | Worst fall | SPY | SPY per year |
| --- | --- | --- | --- | --- | --- |
| 1 year ago | $1,454 | +45.4% | -23.2% | $1,109 | +10.9% |
| 3 years ago | $2,322 | +32.4% | -34.5% | $1,750 | +20.5% |
| 5 years ago | $5,437 | +40.4% | -34.5% | $1,677 | +10.9% |
| 10 years ago | $21,431 | +35.9% | -34.5% | $4,042 | +15.0% |

Today: model fair value $663.67 against a $1354.00 price (gap -51.0%).

Split-adjusted closes; 41 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 6, 2026.

[Full LLY valuation](https://www.equity-rank.com/stocks/LLY) · [Other companies](https://www.equity-rank.com/if-you-invested)

---

Fair value is a model estimate under stated assumptions — not a price target, not a prediction, and not a recommendation. This page is research information, not investment advice. Equity Rank is not a registered investment adviser.